2m 2m 2m 2m 2m 2m 2m
Cytodyn (CYDY)
OTC
$0.29-$0.005 (-1.72%)
Price as of Jun 12, 2026- $397.2MMarket Cap
- -19.35%1-Year Change
- BiotechnologyIndustry
Cytodyn (CYDY)
$0.29-$0.005 (-1.72%)
CYDY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.28 | ||
Change | -$0.005 (-1.72%) | ||
Open | $0.29 | ||
High | $0.31 | ||
Low | $0.28 | ||
Previous Close | $0.29 | ||
Volume | 1,251,624 | ||
30-Day Average Volume | 1,790,119 | ||
1-Week Change | -2.53% | ||
1-Month Change | -18.18% | ||
1-Year Change | -19.35% | ||
3-Year Change | 4.40% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.4B | ||
Total Assets | $18.5M | ||
Market Cap | $397.2M | ||
Enterprise Value | $436.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$5.5M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.7M | ||
Net Working Capital | -$32.0M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -93 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -4 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -72 | ||
Price/Operating Cash Flow | -72 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||